ISSN 2639-9431
Vol. 9, Issue 2, 2026May 12, 2026 EDT
Precision Nanomedicine in Cardiothoracic Oncology: Overcoming the Clinical Paradox of Cisplatin through Supramolecular and Stimuli-Responsive Engineering
Precision Nanomedicine in Cardiothoracic Oncology: Overcoming the Clinical Paradox of Cisplatin through Supramolecular and Stimuli-Responsive Engineering
1.
Wasubhadtanasaka P. Precision Nanomedicine in Cardiothoracic Oncology: Overcoming the Clinical Paradox of Cisplatin through Supramolecular and Stimuli-Responsive Engineering. Precis Nanomed. 2026;9(2):1815-1833. doi:10.33218/001c.161262